The potential role of nanobodies in asthma therapy
Asthma is a chronic inflammatory disease of the airways characterized by bronchoconstriction, airway hyperresponsiveness, and mucus production. The pathophysiology of asthma involves a complex interplay of immune cells and mediators, including cytokines, chemokines, and other inflammatory molecules....
Saved in:
Main Authors: | Baraa Khalid Salah Al-Sheakly, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif-Askari, Jennifer E. Hundt, Rabih Halwani |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1510806/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visual and High-Efficiency Secretion of SARS-CoV-2 Nanobodies with <i>Escherichia coli</i>
by: Shuai Zhao, et al.
Published: (2025-01-01) -
Asthma and obesity increase inflammatory markers in children
by: Harshita Shailesh, et al.
Published: (2025-01-01) -
Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy
by: Baijin Xia, et al.
Published: (2025-03-01) -
GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models
by: Yu Huang, et al.
Published: (2024-12-01) -
Sintering Behavior of CNT Reinforced Al6061 and Al2124 Nanocomposites
by: Nouari Saheb
Published: (2014-01-01)